These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5040251)

  • 1. The determination of the uptake of arabinosyl-6-mercaptopurine by L1210 cells.
    Chao DL; Kimball AP
    Biochim Biophys Acta; 1972 Jun; 266(3):721-5. PubMed ID: 5040251
    [No Abstract]   [Full Text] [Related]  

  • 2. Deamination of arabinosyladenine by adenosine deaminase and inhibition by arabinosyl-6-mercaptopurine.
    Chao DL; Kimball AP
    Cancer Res; 1972 Aug; 32(8):1721-4. PubMed ID: 5044132
    [No Abstract]   [Full Text] [Related]  

  • 3. Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia.
    Kessel D; Shurin SB
    Biochim Biophys Acta; 1968 Sep; 163(2):179-87. PubMed ID: 5686275
    [No Abstract]   [Full Text] [Related]  

  • 4. Riboflavin-methotrexate interactions. Photochemical reaction and competition for transport in the L1210 mouse leukemia cell.
    Lichtenstein NS; Goldman ID
    Biochem Pharmacol; 1970 Apr; 19(4):1229-39. PubMed ID: 5535183
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic nucleotide analogs as carcinostatic agents.
    LePage GA; Hersh EM
    Biochem Biophys Res Commun; 1972 Mar; 46(5):1918-22. PubMed ID: 5015235
    [No Abstract]   [Full Text] [Related]  

  • 6. Uptake and intracellular distribution of 4,4'-diacetyldiphenylurea-bis-(Guanylhydrazone) in sensitive and resistant leukemia L1210 cells.
    Dave C; Mihich E
    Biochem Pharmacol; 1972 Oct; 21(20):2681-95. PubMed ID: 4675029
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of in vivo methotrexate antitumor effect in L1210 leukemia by induced impairment of purine salvage.
    Browman GP; Csullog GW
    Biochem Pharmacol; 1981 Apr; 30(8):869-74. PubMed ID: 7195709
    [No Abstract]   [Full Text] [Related]  

  • 8. Arabinosyl-6-mercaptopurine and arabinosyl-6-mercaptopurine-5'-phosphate: comparison of their metabolic effects.
    LePage GA; Bell JP; Wilson MJ
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):1038-41. PubMed ID: 5791773
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for a membrane sulfhydryl associated with resistance to melphalan in a murine L1210 leukemia line.
    Fisher JM; Naujokaitis AS; Uehara Y; Rabinovitz M
    Biochem Biophys Res Commun; 1983 Dec; 117(3):670-6. PubMed ID: 6667269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts.
    Schrecker AW
    Cancer Res; 1970 Mar; 30(3):632-41. PubMed ID: 5425288
    [No Abstract]   [Full Text] [Related]  

  • 11. A model system for the study of heteroexchange diffusion: methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cells.
    Goldman ID
    Biochim Biophys Acta; 1971 Jun; 233(3):624-34. PubMed ID: 5113921
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
    Belt JA
    Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and metabolism of the periodate oxidation product of 9-beta-D-ribosyl-6-methylthiopurine.
    Bell JP; Gisler RH
    Biochem Pharmacol; 1969 Sep; 18(9):2103-14. PubMed ID: 4310275
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of uracil derivatives on phosphorylation of arabinosylcytosine.
    Grindey GB; Saslaw LD; Waravdekar VS
    Mol Pharmacol; 1968 Jan; 4(1):96-103. PubMed ID: 5640783
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.
    Shrecker AW; Urshel MJ
    Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and biological activity of some new N6-substituted purine nucleosides.
    Fleysher MH; Bloch A; Hakala MT; Nichol CA
    J Med Chem; 1969 Nov; 12(6):1056-61. PubMed ID: 4900616
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine).
    Bach MK
    Cancer Res; 1969 May; 29(5):1036-44. PubMed ID: 5781095
    [No Abstract]   [Full Text] [Related]  

  • 18. Multifactorial cellular determinants of the action of antimetabolites.
    Rustum YM; Grindey GB; Hakala MT; Mihich E
    Adv Enzyme Regul; 1976; 14():281-95. PubMed ID: 184698
    [No Abstract]   [Full Text] [Related]  

  • 19. The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo.
    Young RC; DeVita VT; Perry S
    Cancer Res; 1969 Aug; 29(8):1581-4. PubMed ID: 5807231
    [No Abstract]   [Full Text] [Related]  

  • 20. Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine.
    Bennett LL; Allan PW
    Cancer Res; 1971 Feb; 31(2):152-8. PubMed ID: 5545266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.